title: Current evidence linking polyunsaturated Fatty acids with cancer risk and progression.
abstract: There is increasing evidence that polyunsaturated fatty acids (PUFAs) play a role in cancer risk and progression. The n-3 family of PUFAs includes alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) while the n-6 family includes linolenic acid (LA) and arachidonic acid (AA). EPA and DHA are precursors for anti-inflammatory lipid mediators while AA is a precursor for pro-inflammatory lipid mediators. Collectively, PUFAs play crucial roles in maintaining cellular homeostasis, and perturbations in dietary intake or PUFA metabolism could result in cellular dysfunction and contribute to cancer risk and progression. Epidemiologic studies provide an inconsistent picture of the associations between dietary PUFAs and cancer. This discrepancy may reflect the difficulties in collecting accurate dietary data; however, it also may reflect genetic variation in PUFA metabolism which has been shown to modify physiological levels of PUFAs and cancer risk. Also, host-specific mutations as a result of cellular transformation could modify metabolism of PUFAs in the target-tissue. Clinical trials have shown that supplementation with PUFAs or foods high in PUFAs can affect markers of inflammation, immune function, tumor biology, and prognosis. Pre-clinical investigations have begun to elucidate how PUFAs may mediate cell proliferation, apoptosis and angiogenesis, and the signaling pathways involved in these processes. The purpose of this review is to summarize the current evidence linking PUFAs and their metabolites with cancer and the molecular mechanisms that underlie this association. Identifying the molecular mechanism(s) through which PUFAs affect cancer risk and progression will provide an opportunity to pursue focused dietary interventions that could translate into the development of personalized diets for cancer control.
authors.affiliation: Department of Nutrition Sciences, University of Alabama at Birmingham , Birmingham, AL , USA.
authors.forename: Maria
authors.initials: M
authors.lastname: Azrad
authors.forename: Chelsea
authors.initials: C
authors.lastname: Turgeon
authors.forename: Wendy
authors.initials: W
authors.lastname: Demark-Wahnefried
keywords: cancer; clinical trials; clinical trials as topic; epidemiologic studies; phase II as topic; polyunsaturated fatty acids; pre-clinical testing; review of literature
references.citation: Int J Cancer. 2009 Feb 15;124(4):924-31
references.pmid: 19035453
references.citation: Int J Cancer. 2011 Oct 1;129(7):1718-29
references.pmid: 21120874
references.citation: PLoS One. 2012;7(12):e53104
references.pmid: 23285256
references.citation: Br J Nutr. 2012 Jul;108(2):327-33
references.pmid: 22114792
references.citation: Mol Nutr Food Res. 2007 Jul;51(7):845-56
references.pmid: 17579892
references.citation: Int J Cancer. 2007 Aug 1;121(3):520-7
references.pmid: 17415712
references.citation: Int J Biochem Cell Biol. 2010 Jul;42(7):1061-5
references.pmid: 20348011
references.citation: Cancer Causes Control. 2011 Jan;22(1):141-50
references.pmid: 21103921
references.citation: J Nutr. 2010 Oct;140(10):1774-80
references.pmid: 20739445
references.citation: Nat Med. 2012 Jan 22;18(2):224-6
references.pmid: 22270723
references.citation: Biochem Biophys Res Commun. 2012 Apr 6;420(2):428-33
references.pmid: 22426480
references.citation: Cancer Prev Res (Phila). 2012 Feb;5(2):216-28
references.pmid: 22166249
references.citation: J Clin Endocrinol Metab. 2005 May;90(5):2563-70
references.pmid: 15687328
references.citation: Nutr Cancer. 2012;64(8):1131-42
references.pmid: 23137008
references.citation: Cell Div. 2009 Apr 02;4:6
references.pmid: 19341447
references.citation: Nature. 2004 Sep 23;431(7007):405-6
references.pmid: 15385993
references.citation: Eur J Clin Nutr. 2012 Mar;66(3):399-404
references.pmid: 22234041
references.citation: Annu Rev Immunol. 2007;25:101-37
references.pmid: 17090225
references.citation: Nutr Metab (Lond). 2009 Feb 19;6:8
references.pmid: 19228394
references.citation: Mediators Inflamm. 1992;1(1):5-8
references.pmid: 18475433
references.citation: Br J Nutr. 2012 Jun;107 Suppl 2:S228-39
references.pmid: 22591896
references.citation: Biomed Pharmacother. 2006 Nov;60(9):502-7
references.pmid: 17045449
references.citation: Int J Mol Med. 2003 Aug;12(2):253-7
references.pmid: 12851727
references.citation: Br J Surg. 2012 Mar;99(3):346-55
references.pmid: 22237467
references.citation: J Pharmacol Sci. 2007 Jan;103(1):24-32
references.pmid: 17220595
references.citation: Biochem Biophys Res Commun. 2005 Sep 30;335(3):949-56
references.pmid: 16105664
references.citation: Mol Genet Metab. 2011 Jun;103(2):171-8
references.pmid: 21414826
references.citation: Free Radic Biol Med. 2012 May 1;52(9):2013-37
references.pmid: 22391222
references.citation: Cancer Metastasis Rev. 2011 Dec;30(3-4):363-85
references.pmid: 22134655
references.citation: Mol Carcinog. 2007 Nov;46(11):912-23
references.pmid: 17427962
references.citation: PLoS Genet. 2009 Jan;5(1):e1000338
references.pmid: 19148276
references.citation: Exp Biol Med (Maywood). 2010 Jul;235(7):785-95
references.pmid: 20558833
references.citation: Am J Clin Oncol. 2011 Dec;34(6):573-80
references.pmid: 21217399
references.citation: Am J Clin Nutr. 2011 May;93(5):950-62
references.pmid: 21367944
references.citation: Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):591-6
references.pmid: 14688410
references.citation: Br J Pharmacol. 2012 Jul;166(5):1724-37
references.pmid: 22300262
references.citation: Hum Mol Genet. 2006 Jun 1;15(11):1745-56
references.pmid: 16670158
references.citation: PLoS Genet. 2011 Jul;7(7):e1002193
references.pmid: 21829377
references.citation: Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):697-707
references.pmid: 23549401
references.citation: J Lipid Res. 2004 Feb;45(2):308-16
references.pmid: 14563831
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2283-91
references.pmid: 19661088
references.citation: Nutr Cancer. 2011;63(6):960-70
references.pmid: 21774594
references.citation: Int J Cancer. 2011 Mar 15;128(6):1434-41
references.pmid: 20878979
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):516-25
references.pmid: 19190143
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3577-87
references.pmid: 19064574
references.citation: Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):3-8
references.pmid: 11205486
references.citation: J Natl Cancer Inst. 2012 May 2;104(9):645-7
references.pmid: 22472307
references.citation: Nutrition. 2012 Jan;28(1):67-75
references.pmid: 21795022
references.citation: Br J Clin Pharmacol. 2013 Mar;75(3):645-62
references.pmid: 22765297
references.citation: Cancer Causes Control. 2004 May;15(4):367-86
references.pmid: 15141138
references.citation: Ann N Y Acad Sci. 2009 Aug;1171:190-5
references.pmid: 19723055
references.citation: Nature. 2011 Feb 10;470(7333):214-20
references.pmid: 21307934
references.citation: Blood. 2008 Apr 1;111(7):3514-21
references.pmid: 18216296
references.citation: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1751-6
references.pmid: 12578976
references.citation: J Biol Chem. 2008 Feb 8;283(6):3433-3444
references.pmid: 18083712
references.citation: Nutr Cancer. 2008;60(5):666-74
references.pmid: 18791931
references.citation: Lipids. 2012 Apr;47(4):383-9
references.pmid: 22160495
references.citation: BMC Genet. 2011 May 20;12:50
references.pmid: 21599946
references.citation: Cancer. 2011 Aug 15;117(16):3774-80
references.pmid: 21328326
references.citation: BMC Med. 2012 May 21;10:50
references.pmid: 22613931
references.citation: Annu Rev Nutr. 2004;24:345-76
references.pmid: 15189125
references.citation: Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):915-20
references.pmid: 19286633
references.citation: J Natl Cancer Inst. 2009 Jul 15;101(14):1001-11
references.pmid: 19561318
references.citation: Cancer Metastasis Rev. 2011 Dec;30(3-4):481-91
references.pmid: 22037943
references.citation: Int J Cancer. 2004 Apr 10;109(3):449-54
references.pmid: 14961586
references.citation: Endocrinology. 2013 May;154(5):1768-79
references.pmid: 23515290
references.citation: Cancer Prev Res (Phila). 2011 Dec;4(12):2062-71
references.pmid: 22027686
references.citation: Cancer Invest. 2008 Feb;26(1):68-73
references.pmid: 18181048
references.citation: J Biol Chem. 2012 Apr 20;287(17):13840-9
references.pmid: 22396544
references.citation: Thorax. 2010 Apr;65(4):321-6
references.pmid: 20388757
references.citation: Nat Rev Cancer. 2010 Mar;10(3):181-93
references.pmid: 20168319
references.citation: Cancer Metastasis Rev. 2011 Dec;30(3-4):449-63
references.pmid: 22002714
references.citation: Clin Cancer Res. 2006 Oct 1;12(19):5879-86
references.pmid: 17020996
references.citation: MMWR Morb Mortal Wkly Rep. 2004 Feb 6;53(4):80-2
references.pmid: 14762332
references.citation: Br J Nutr. 2012 Nov 28;108(10):1764-72
references.pmid: 22244053
references.citation: Mol Cancer Res. 2009 Sep;7(9):1417-24
references.pmid: 19737966
references.citation: Cancer. 2011 Apr 15;117(8):1775-82
references.pmid: 21360698
references.citation: CA Cancer J Clin. 2013 Jan;63(1):11-30
references.pmid: 23335087
references.citation: Nature. 1996 Nov 7;384(6604):39-43
references.pmid: 8900274
references.citation: PLoS One. 2011;6(9):e24004
references.pmid: 21912659